Publications and Further Research Outputs
- Orfali N., Jhanwar Y., Koo C., Pasciolla M., Baldo M., Cuvilly E., Furman R., Gergis U., Greenberg J., Guarneri D., Hsu J.-M., Leonard J.P., Mark T., Mayer S., Maignan K., Martin P., Opong A., Pearse R., Phillips A., Rossi A., Ruan J., Rutherford S.C., Ryan J., Suhu G., Van Besien K., Shore T., Sequential intensive chemotherapy followed by autologous or allogeneic transplantation for refractory lymphoma, Leukemia and Lymphoma, 2021Journal Article, 2021, DOI
- Van Besien K., Orfali N., Shore T., Allogeneic Transplant Conditioning Regimens for Patients with Non-Hodgkin Lymphoma, JAMA Oncology, 6, (12), 2020, p1980-Journal Article, 2020, DOI
- Chaekal O.-K., Scaradavou A., Frenet E.M., Albano M.S., Cushing M., Desai P., Dobrila L., Gergis U., Guarneri D., Hsu J.-M., Lee S., Mayer S.A., Phillips A.A., Orfali N., Ritchie E.K., Roboz G.J., Romeo C., Samuel M.S., Shore T., van Besien K., Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and response, Blood Advances, 4, (20), 2020, p5146 - 5156, p5146-5156Journal Article, 2020, DOI
- Gomez-Arteaga A., Orfali N., Guarneri D., Cushing M.M., Gergis U., Hsu J., Hsu Y.-M.S., Mayer S.A., Phillips A.A., Chase S.A., Mokhtar A.E., Shore T.B., Van Besien K., Cord blood transplants supported by unrelated donor CD34+ progenitor cells, Bone Marrow Transplantation, 55, (12), 2020, p2298 - 2307, p2298-2307Journal Article, 2020, DOI
- Salvatore M., Laplante J.M., Soave R., Orfali N., Plate M., van Besien K., St. George K., Baloxavir for the treatment of Influenza in allogeneic hematopoietic stem cell transplant recipients previously treated with oseltamivir, Transplant Infectious Disease, 22, (4), 2020Journal Article, 2020, DOI
- Van Besien K.W., Orfali N., Alternative donor transplantation for lymphoid malignancies: How far we have come, Journal of Clinical Oncology, 38, (14), 2020, p1501 - 1504, p1501-1504Journal Article, 2020, DOI
- Orfali N., van Besien K., Combining haplo-identical and cord blood stem cell grafts"might the whole be greater than the sum of its parts?, Leukemia and Lymphoma, 61, (4), 2020, p753 - 756, p753-756Journal Article, 2020, DOI
- Orfali N., Shan-Krauer D., O'Donovan T.R., Mongan N.P., Gudas L.J., Cahill M.R., Tschan M.P., McKenna S.L., Inhibition of UBE2L6 attenuates ISGylation and impedes ATRA-induced differentiation of leukemic cells, Molecular Oncology, 14, (6), 2020, p1297 - 1309, p1297-1309Journal Article, 2020, DOI
- Orfali N., O'Donovan T.R., Cahill M.R., Benjamin D., Nanus D.M., McKenna S.L., Gudas L.J., Mongan N.P., All-trans retinoic acid (ATRA)-induced TFEB expression is required for myeloid differentiation in acute promyelocytic leukemia (APL), European Journal of Haematology, 104, (3), 2020, p236 - 250, p236-250Journal Article, 2020, DOI
- Orfali N., Jeyapalan J.N., Woodcock C.L., O'Donovan T.R., Benjamin D., Cahill M., McKenna S., Gudas L.J., Mongan N.P., Lentiviral-Mediated shRNA Approaches: Applications in Cellular Differentiation and Autophagy, Methods in Molecular Biology, 2019, 2019, p33 - 49, p33-49Journal Article, 2019, DOI
- Orfali N., McKenna S.L., Cahill M.R., Gudas L.J., Mongan N.P., Retinoid receptor signaling and autophagy in acute promyelocytic leukemia, Experimental Cell Research, 324, (1), 2014, p1 - 12, p1-12Journal Article, 2014, DOI
- Orfali N., O'Donovan T.R., Nyhan M.J., Britschgi A., Tschan M.P., Cahill M.R., Mongan N.P., Gudas L.J., McKenna S.L., Induction of autophagy is a key component of all-trans-retinoic acid-induced differentiation in leukemia cells and a potential target for pharmacologic modulation, Experimental Hematology, 43, (9), 2015, p781 - 793.e2, p781-793.e2Journal Article, 2015, DOI
- Kloesel B., Musibay E.D., Pedersen K., Orfali N., Mattingley J., Vassallo R., A 64-year-old man with progressive dyspnea and cough productive of copious amounts of clear sputum, Chest, 141, (6), 2012, p1622 - 1625, p1622-1625Journal Article, 2012, DOI